BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2475365)

  • 1. The time course of liver injury and [3H]thymidine incorporation in chlordecone-potentiated CHCl3 hepatotoxicity.
    Mehendale HM; Purushotham KR; Lockard VG
    Exp Mol Pathol; 1989 Aug; 51(1):31-47. PubMed ID: 2475365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivotal role of hepatocellular regeneration in the ultimate hepatotoxicity of CCl4 in chlordecone-, mirex-, or phenobarbital-pretreated rats.
    Kodavanti PR; Kodavanti UP; Faroon OM; Mehendale HM
    Toxicol Pathol; 1992; 20(4):556-69. PubMed ID: 1284994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of chloroform hepatotoxicity and lethality by dietary chlordecone (kepone) in mice.
    Purushotham KR; Lockard VG; Mehendale HM
    Toxicol Pathol; 1988; 16(1):27-34. PubMed ID: 2453913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity and lethality of halomethanes in Mongolian gerbils pretreated with chlordecone, phenobarbital or mirex.
    Cai Z; Mehendale HM
    Arch Toxicol; 1991; 65(3):204-12. PubMed ID: 1711308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbations in polyamines and related enzymes following chlordecone-potentiated bromotrichloromethane hepatotoxicity.
    Rao SB; Young RA; Mehendale HM
    J Biochem Toxicol; 1990; 5(1):23-32. PubMed ID: 1698228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo metabolism of CCl4 by rats pretreated with chlordecone, mirex, or phenobarbital.
    Mehendale HM; Klingensmith JS
    Toxicol Appl Pharmacol; 1988 Apr; 93(2):247-56. PubMed ID: 2451866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: regeneration studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):58-66. PubMed ID: 1706540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dietary exposure to a mirex plus chlordecone combination on CCl4 hepatotoxicity.
    Bell AN; Mehendale HM
    Fundam Appl Toxicol; 1985 Aug; 5(4):679-87. PubMed ID: 2412926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Destruction of hepatic mixed-function oxygenase parameters by CCl4 in rats following acute treatment with chlordecone, Mirex, and phenobarbital.
    Klingensmith JS; Mehendale HM
    Life Sci; 1983 Dec; 33(23):2339-48. PubMed ID: 6196592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromotrichloromethane hepatotoxicity. The role of stimulated hepatocellular regeneration in recovery: biochemical and histopathological studies in control and chlordecone pretreated male rats.
    Faroon OM; Mehendale HM
    Toxicol Pathol; 1990; 18(4 Pt 2):667-77. PubMed ID: 1709515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relationships between biotransformation, detoxication, and chlordecone potentiation of chloroform-induced hepatotoxicity.
    Hewitt LA; Caillé G; Plaa GL
    Can J Physiol Pharmacol; 1986 Apr; 64(4):477-82. PubMed ID: 2425914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatocellular regeneration in chlordecone potentiated hepatotoxicity of carbon tetrachloride.
    Kodavanti PR; Joshi UM; Young RA; Bell AN; Mehendale HM
    Arch Toxicol; 1989; 63(5):367-75. PubMed ID: 2479360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PB-PK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital, or mirex.
    Thakore KN; Gargas ML; Andersen ME; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Jul; 109(3):514-28. PubMed ID: 1712992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal effects of CCl4 and its metabolism by Mongolian gerbils pretreated with chlordecone, phenobarbital, or mirex.
    Cai ZW; Mehendale HM
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):511-20. PubMed ID: 1696756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related susceptibility to chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality is due to hepatic quiescence.
    Dalu A; Warbritton A; Bucci TJ; Mehendale HM
    Pediatr Res; 1995 Aug; 38(2):140-8. PubMed ID: 7478807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of halomethane hepatotoxicity: chlordecone and carbon tetrachloride.
    Mehendale HM
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 1):295-308. PubMed ID: 6204898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance of aged Fischer 344 rats against chlordecone-amplified carbon tetrachloride toxicity.
    Murali B; Korrapati MC; Warbritton A; Latendresse JR; Mehendale HM
    Mech Ageing Dev; 2004 Jun; 125(6):421-35. PubMed ID: 15178132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of bromotrichloromethane hepatotoxicity and lethality by chlordecone preexposure in the rat.
    Agarwal AK; Mehendale HM
    Fundam Appl Toxicol; 1982; 2(4):161-7. PubMed ID: 6193023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered hepatic energy status in chlordecone (Kepone)-potentiated CCl4 hepatotoxicity.
    Kodavanti PR; Kodavanti UP; Mehendale HM
    Biochem Pharmacol; 1990 Aug; 40(4):859-66. PubMed ID: 1696822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatotoxicity and lethality of CCl4 in chlordecone-pretreated rats.
    Klingensmith JS; Lockard V; Mehendale HM
    Exp Mol Pathol; 1983 Aug; 39(1):1-10. PubMed ID: 6192011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.